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Abstract 
Hyperplasia of the pancreatic tissue during late lactation (third week) and lasting for at least the first two weeks after weaning has 
been observed by several authors. Since the tetradecapeptide somatostatin (SS) inhibits pancreatic growth and its plasma levels are 
elevated uring these periods, the aim of the present study was to determine the possible implication of the somatostatinergic system in 
the pancreatic changes cited above. Thus, the present study investigated 125 i_Tyrll.somatostatin (125I-Tyrll-SS) binding and the effects of 
SS on guanylate cyclase activity as well as pancreatic somatostatin-like immunoreactivity (SSLI) levels in pancreatic acinar membranes 
from control, lactating and weaning rats. SS receptors were identified using 125I-Tyrl~-SS and isolated pancreatic acinar membranes in
vitro. There was an increase in the number of SS receptors after the third week of lactation (244 _+ 6 vs. 155 +_ 12 fmol/mg protein, 
P < 0.01) and the first two weeks after weaning (327 _+ 8 vs. 164 + 10 fmol/mg protein, P < 0.001). No change in the affinity of the 
receptor site was detected at either study time. In addition, SS-stimulated guanylate cyclase activity was markedly increased at the third 
week of lactation (119%) and at the second week after weaning (158%) when compared with the control group. In contrast, basal 
guanylate cyclase activity was not modified at either study period. Thus, SS-stimulated guanylate cyclase activity is increased in 
pancreatic acinar membranes atlate lactation and at the second week after beginning weaning probably due to an increase in the number 
of SS receptors. Significant decreases in SSLI content were observed at the third week of lactation (69%) and the second week after 
weaning (37%) when compared with the respective controls. The present results suggest that pancreatic acinar cell growth observed at the 
third week of lactation and the second week after weaning is associated with up-regulation of SS receptors which would represent a
mechanism promoted by the cell that would negatively regulate the mitogenic activity of the increased number of pancreatic growth 
factors observed uring both periods. 
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1. Introduction 
During lactation, gastrointestinal tract weight increases 
and then returns to normality after weaning [1,2]. The 
weight of the pancreas, which is part of the gastrointestinal 
Abbreviations: SS, somatostatin; 12SI-Tyrll-SS, 125I-Tyrll-soma- 
tostatin; SSLI, somatostatin-like immunoreactivity; CCK, cholecysto- 
kinin; PMSF, phenylmethylsulphonylfluoride; GTP, guanosine triphos- 
phate; IBMX, 3-isobutyl-l-methylxanthine; BSA, bovine serum albumin, 
VIP, vasoactive intestinal peptide. 
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system, also increased during lactation [3]. Hypertrophy 
and hyperplasia of pancreatic tissue occurred after the third 
week of lactation reaching a maximum at the end of the 
second week post-lactation [3]. The time course of these 
modifications eems to be related to an increase in food 
intake and is probably mediated by the endogenous release 
of some gastrointestinal hormones uch as cholecystokinin 
(CCK), gastrin and secretin, known for their trophic effect 
on the pancreas [1,4]. A rise in tetradecapeptide somato- 
statin (SS) levels in plasma in response to suckling has 
recently been described [5]. In addition to the intestinal 
mucosa, which preferentially releases omatostatin-28 [6], 
a major site of endogenous SS release is located within the 
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pancreas itself, namely in the D-cells of the islets of 
Langerhans [7-9]. To date, it is unknown whether SS, an 
inhibitor of pancreatic growth [10,11], is involved in the 
regulation of the pancreatic acinar cell proliferation ob- 
served during lactation. Previous studies by other authors 
[12] and ourselves uggest that SS appears to be negatively 
involved in the hyperplasic responses of pancreatic acinar 
cells after subtotal enterectomy [13] or pentagastrin admin- 
istration [14]. Normal rat pancreatic acinar cell membranes 
possess specific SS receptors [15-17]. The cyclic AMP 
pathway has been reported to not be involved in the 
inhibitory effect of SS on exocrine pancreatic hyperplasia 
observed after proximal small bowel resection [13] or of 
SS analogue SMS 201-995 on AR4-2J pancreatic tumor 
cell growth [18]. It has been reported that SS increases the 
level of the second messenger cyclic GMP (cGMP) in rat 
pancreas as well as in other tissues [19,20]. Recent studies 
support a role for cGMP in the antiproliferative effect of 
SS [21]. SS also activates a receptor-associated yrosine 
phosphatase which is thought o be involved in cell growth 
control [22]. 
The present study examined the effect of lactation and 
weaning on the density of 125I-Tyr~l-somatostatin (1251- 
Tyrl~-SS) receptors and SS-mediated guanylate cyclase 
activity in pancreatic acinar membranes from rats. Because 
there was a close interaction between the islets of Langer- 
hans and the exocrine pancreas, which appears in part to 
be mediated by an insulino-acinar portal system [23,24], 
somatostatin-like immunoreactivity (SSLI) levels in the 
pancreas of these animals were also studied. 
2. Materials and methods 
2.1. Materials 
Synthetic TyrI~-ss was purchased from Universal Bio- 
logicals Ltd. (Cambridge, UK); collagenase (from 
Clostridium histoliticum) was obtained from Serva Fine 
Chemicals (Tebu, France). Bacitracin, PMSF, GTP, IBMX 
and BSA were purchased from Sigma (St. Louis, MO, 
USA). Cartier-free Na[125I] (IMS 300, 100 mCi/ml), the 
rabbit antibody used in the radioimmunoassay technique 
and the cGMP kit were purchased from the Radiochemical 
Center (Amersham, UK). This antiserum was raised in 
rabbits against SS-14 conjugated to BSA and is specific 
for SS, but since SS-14 constitutes the C-terminal portion 
of both SS-25 and SS-28, the antiserum does not distin- 
guish between these three forms. 
2.2. Experimental nimals 
A population of fifteen newborn female Wistar rats 
from our own colony was selected at birth and maintained 
until they were three months old. All animals were allowed 
ad libitum access to a commercial diet and drinking water, 
in a room maintained at a temperature of 20°C-22°C and 
with 12:12 light/dark schedule. At this age, ten females 
were selected at random for impregnation, while the others 
were designated as unmated controls. The presence of 
spermatozoa in the vaginal smear the next morning was 
regarded as evidence of impregnation. The day of parturi- 
tion was considered as day 0 of lactation. Lactation was 
permitted for 21 days following delivery. Eight animals 
were sacrificed by decapitation after the third week of 
lactation and the rest the second week after weaning, since 
pancreatic tissue hyperplasia occurs late during lactation 
(third week after birth) and reaches its maximum at the 
end of the second week post-lactation (fifth week after 
birth) [3]. The pancreas was removed and trimmed free of 
fat, connective tissue and lymph nodes. 
2.3. Preparation of rat pancreatic acinar membranes 
Dispersed pancreatic acini were obtained from female 
Wistar rats after enzymatic degradation of the pancreas 
with 0.2 U of collagenase/ml in an oxygenated Krebs- 
Ringer medium as described by Amsterdam et al. [25]. 
After washing by sedimentation, acini were transferred to 
0.3 M sucrose, 0.03% soybean trypsin inhibitor, 0.1 mM 
PMSF and 1 mM benzamidine (buffer A). In this buffer, 
the acini were homogenized at 4°C by use of a Potter 
homogenizer. After centrifugation at600 × g at 4°C for 5 
min, the supernatant was resuspended in buffer A and 
centrifuged at 100000 × g in a TLA 100.3 rotor at 4°C for 
1 h. The supernatant was discarded and the pellet was 
resuspended in 50 mM Tris/HC1, pH 7, 0.5 mg/ml 
bacitracin, 0.2 mM CaC12, 0.03% soybean trypsin in- 
hibitor, 0.1 mM PMSF, 1 mM benzamidine and 5% glyc- 
erol (buffer B). An aliquot was taken for protein determi- 
nation by the method of Lowry et al. [26] with BSA as a 
standard. 
2.4. Binding of [125I-Tyr ll]ss 
[ 125I-Tyr 11 ]SS was radioiodinated by chloramine-T iod- 
ination according to the method of Greenwood [27]. Sepa- 
ration of iodinated SS from unincorporated iodine was 
carried out on a Sephadex G-25 (fine) column equilibrated 
and eluted with 0.1 M acetic acid in BSA (0.1% w/v). 
The specific activity of the radioligand was 600 Ci/mmol. 
Binding of 125I-Tyr11-SS was assayed on pancreatic 
acinar membranes from rats by a modified method [22]. 
Binding of [125I-Tyr~l]ss to pancreatic acinar membranes 
was carried out in a total volume of 250 /xl in 50 mM 
Tris-HC1 buffer (pH 7.4) containing 0.5 mM MgCI 2, 3 
mM NaC1, 0.2 mM CaC12, 0.2% (w/v)  BSA, 0.5 mg/ml 
bacitracin and 0.3 mg/ml soybean trypsin inhibitor (bind- 
ing buffer). Plasma membranes (100 /xg of protein/ml) 
were incubated at 20°C for 90 min with 100 pM [1251- 
TyrH]SS in the absence or presence of unlabelled SS. 
Bound and free ligand were separated by centrifugation at
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11 000 × g at 4°C for 4 rain in a microcentrifuge. Radioac- 
tivity in the pellet was measured with a gamma scintilla- 
tion counter. Non-specific binding was estimated as mem- 
brane-associated ra ioactivity in the presence of 1 /xM SS 
and specific binding was calculated as the difference be- 
tween total and non-specific membrane-associated radioac- 
tivity. 
2.5. Evaluation of radiolabelled peptide degradation 
To determine the extent of tracer degradation during 
incubation, we measured the ability of preincubated pep- 
tide to bind to fresh pancreatic acinar membranes. Briefly, 
[125I-Tyrll]ss (100 pM) was incubated with pancreatic 
acinar membranes (100 /zg protein/ml) at 20°C for 90 
rain. After this preincubation, aliquots of the medium were 
added to fresh pancreatic acinar membranes and incubated 
at 20°C for an additional 90 min. The fraction of the added 
radiolabelled peptide which specifically bound during the 
second incubation was measured and expressed as a per- 
centage of the binding that was obtained in control experi- 
ments performed in the absence of pancreatic acinar mem- 
branes during the preincubation period. Pancreatic acinar 
cell membranes from all the groups showed a similar 
peptide degradation capacity and the values varied by no 
more than 9% in all the experimental groups. 
2.6. Measurement of the particulate guanylate cyclase 
activity 
The activity of particulate guanylate cyclase in pancre- 
atic acinar membranes was measured using the method 
previously described [28,29] with a slight modification. 
The pancreatic acinar membranes (50 /~g protein/10 /~1) 
were resuspended in 50 mM Tris-HC1, pH 7.6 and used for 
the assay of guanylate cyclase activity. A 10 ~1 aliquot 
was added to tubes containing 80 /~1 of a reaction mixture 
containing (final concentrations) 50mM Tris-HC1, pH 7.6, 
40 mM MnC12, 1 mM GTP, 1 mM IBMX, 0.01% baci- 
tracin, and a GTP-regenerating system that consisted of 15 
mM creatine phosphate and 20 /xg of creatine phosphoki- 
nase. After incubation at 37°C for 10 rain with or without 
SS (10 -7 M-10-12 M) the reaction was stopped by the 
addition of 900 /xl of 50 mM sodium acetate, pH 4.0, 
followed by heating at 90°C for 3 min. The heated incuba- 
tion mixture was centrifuged at 2000 X g for 20 rain and 
the supernatant fraction was evaporated to dryness. The 
amount of cGMP generated was determined in the dry 
extract by radioimmunoassay. 
2.7. Tissue extraction and SS radioimmunoassay 
For SSLI measurement, the pancreas were rapidly ho- 
mogenized in 1 ml 2 M acetic acid using a Brinkman 
polytron (setting 5, 30 s). The extracts were boiled for 5 
min, cooled in an ice-chilled water-bath, and aliquots (100 
/zl) were removed for protein determination [26]. The 
homogenates were subsequently centrifuged at 15 000 × g 
at 4°C for 15 min and the supernatant was neutralized with 
2 M NaOH. The extracts were stored at -70°C until 
assay. The SS concentration was determined in tissue 
extracts by a modified radioimmunoassay method [30], 
with a sensitivity limit of 10 pg/ml. Incubation tubes 
prepared in duplicate contained 100 /zl of samples of 
tissue extracts or standard solutions of 0-500 pg cyclic 
SS-14 diluted in phosphate buffer (0.05 M, pH 7.2, con- 
taining 0.3% BSA, 0.01 M EDTA), 200 /zl of appropri- 
ately diluted anti-SS-serum, 100 /~1 of freshly prepared 
[125I-TyrI1]SS diluted in buffer to give 6000 cpm (equiv- 
alent to 5-10 pg), in a final volume of 0.8 ml. All reagents 
as well as the assay tubes were kept chilled on ice before 
their incubation at 4°C for 48 h. Bound hormone was 
separated from free hormone by the addition of 1 ml of 
dextran-coated charcoal (dextran T-70, 0.2% w/v ,  Phar- 
macia, Uppsala, Sweden; charcoal: Norit A, 2% w/v,  
Serva, Feinbiochemica, Heidelberg, Germany). Serial dilu- 
tion curves for the samples were parallel with the standard 
curve. The intra and inter-assay variation coefficients were 
6.0 and 8.8%, respectively. 
2.8. Data analysis 
The computer program LIGAND [31] was used to 
analyze the binding data. The use of this program made it 
possible to select the receptor models which best fit a 
given set of binding data. The same program was also used 
to present data in the form of Scatchard plots [32] and to 
compute the values for receptor affinity (K d) and density 
(Bma x) that best fit the sets of binding data for each rat. 
Statistical comparisons of all the data were analyzed by 
ANOVA and the Newman-Keuls t-test. Means among 
groups were considered significantly different when the P 
value was less than 0.05. Each individual experiment was 
performed in duplicate. 
3. Results 
At the third week of lactation and the second week after 
weaning, pancreas weight was greater than that in the 
respective controls (1205 ___ 54 vs. 798 _+ 26 mg, P < 0.05; 
1001 _ 32 vs. 805 +__ 31 mg, P < 0.01 respectively). 
The specific binding of ~25I-Tyr11-SS to pancreatic aci- 
nar membranes was time dependent in all the experimental 
groups. An apparent equilibrium was observed between 60 
and 120 min at 20°C (data not shown). All subsequent 
binding experiments were therefore conducted at 20°C for 
90 rain. Peptide degradation was determined torule out the 
possibility of differences in SS degrading activities be- 
tween the preparations, which could have affected the 
interpretation of the results. Pancreatic acinar membranes 
from each experimental group showed a similar peptide 
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inhibition of specific 125I-TyrlLsoma- 
tostatin (125I-Tyr11-SS) binding to rat pancreatic acinar membranes by 
unlabelled somatostatin. Points correspond to control (O), lactating (third 
week; O)  and weaning (second week; r, ) rats. Each point is the mean of 
five rats per group performed in duplicate. Results express the value of a 
pool of control groups because maximal binding capacity and dissociation 
constant values of the control groups were not affected. For the sake of 
clarity, S.E.M. are not represented but were always below 10% of mean 
values. Right panel: Scatchard analysis of the same data. The kinetic 
constants calculated by Scatchard analysis are given in Table 1. The 
calculated pancreatic SS receptor affinity values were 252 pM in control 
rats and 279 pM and 290 pM in lactating and weaning rats, respectively. 
degradation capacity, and the values varied no more than 
10% among experimental groups. 
Increasing concentrations of unlabelled SS competi- 
tively inhibited the specific binding of ~zSI-Tyrl]-SS to rat 
pancreatic acinar membranes in the preparations from both 
control and experimental groups (Fig. 1 left panel). How- 
ever, at the third week of lactation and second week after 
weaning the specific binding of the tracer in both groups 
was significantly higher than in the control animals (Fig. 1 
left panel). Analyzing the stoichiometric data by the method 
of Scatchard [32], the values for SS binding to the prepara- 
tions were linear (Fig. 1 right panel). Interpretation with 
Table 1 
Equilibrium dissociation constants and maximum binding capacities of 
the female rat exocrine pancreas omatostatin (SS) receptor at the third 
week of lactation and the second week after weaning 
Groups SS receptors 
Bmax Kd 
( fmol /mg protein) (nM) 
controls 155 ± 12 0.34 ± 0.02 
lactation 244 ± 6 * * 0.39 ± 0.05 
(third week) 
controls 164 ± 10 0.35 ± 0.03 
weaning 327 ± 8 * * * 0.41 ± 0.04 
(second week) 
Binding parameters were obtained by computer nonlinear regression 
analysis (ligand) of individual competitive binding curves. Each value is 
the mean ± S.E.M. of five rats per group performed in duplicate. Compar- 
ison of means within each parameter group was by one-way ANOVA and 
Newman-Keuls tests. Statistical comparison vs. control: * * P < 0.01; 
• ** P<0.001.  
Table 2 
Effect of somatostatin (SS) on basal guanylate cyclase activity (pmol 
cGMP/10 min per mg protein) in pancreatic acinar membranes of 
control, lactating (third week) and weaning (second week) rats 
[SS] Control Lactation Weaning 
(third week) (second week) 
0 9.4±0.5 9.4±0.5 9.1±0.3 
lpM 10.6±0.1 12.0±1.7 12.2±2.0 
10pM 11.5±0.02 14.0±0.8" 14.2±2.5 
100pM 12.7±1.6 16.0±1.7 17.8±3.5 
lnM 14.4±0.4 20 .6±0.7 ' **  23 .5±1.9"*  
10nM 12.1±0.3 16.4±2.4 17.4±2.7 
100nM 11.1±0.5 14.0±3.6 12.8±1.6 
Each value is the mean±S.E.M, of five rats per group performed in 
duplicate. Comparison of means within each parameter group was by 
one-way ANOVA and Newman-Keuls tests. Statistical comparison vs. 
control: * P<0.05 ,  ** P<0.01 ,  *** P<0.001.  Calculated 50% in- 
hibitory concentration values were 11 pM in control rats and 16 pM and 
24 pM in lactating and weaning rats, respectively. 
the LIGAND computer program [31] resulted in the best fit 
for a model of a single class of receptors for the ligand. 
Table 1 shows the corresponding equilibrium parameters 
for the SS receptors. At the third week of lactation and at 
the second week after weaning, the number of receptors in 
the pancreatic acinar membranes were respectively in- 
creased 57% and 99%, without affecting the affinity con- 
stant. 
Guanylate cyclase activity was measured in pancreatic 
acinar membranes from all the study groups (Table 2). No 
significant differences were seen for basal guanylate cy- 
clase activity between the control and experimental groups 
at any of the studied times. The capacity of SS to stimulate 
guanylate cyclase activity in all the groups is shown in 
Table 2. SS stimulated guanylate cyclase activity in control 
and experimental groups. However, the effect of SS on 
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Fig. 2. Pancreatic somatostatin-like immunoreactivity (SSLI) content in 
control (open bars), lactating (third week; black bar) and weaning (second 
week; hatched bar) rats. Values are expressed as the mean ± S.E.M. in ng 
SS/g  of wet pancreatic weight for five rats per group performed in 
duplicate. Statistical comparison vs. control: * P < 0.05, * * P < 0.01. 
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guanylate cyclase activity was markedly increased in pan- 
creatic acinar membranes from rats at the third week of 
lactation (119%) and at the second week after weaning 
(158%) when compared with the control group. The differ- 
ence of the increase of guanylate cyclase activity observed 
between the late lactation and weaning roup is not statisti- 
cally significant. 
Fig. 2 shows the effects of lactation and weaning on 
pancreatic SSLI content. Significant decreases in SSLI 
content were observed at the third week of lactation (69%) 
and at the second week after weaning (37%) when com- 
pared with the respective controls. 
4. Discussion 
Lactation and weaning increased pancreatic growth and 
this effect was associated with an increase in the number 
of SS receptors without changes in affinity. 
The mechanism responsible for the increased number of 
SS receptors at late lactation and at the second week after 
weaning is uncertain. However, it could be explained by 
the indirect effect of either decreased SSLI or an increase 
in the number of acinar cells expressing SS receptors. In 
this regard, Joliceur et al. [3] have found that the increase 
in the number of acinar cells associated with lactation 
reaches its maximum at the end of the second week 
post-lactation. Since growth factor-induced cell division is 
paralleled by heteroregulation f other cell surface recep- 
tors [33], it is possible that SS receptors are targets for 
heterologous regulation by growth factors. Thus, the in- 
crease in SS receptors could be secondary to the mitogenic 
signal of CCK [34], given the increase of its plasma levels 
in this present situation. It is well known that cell surface 
receptor regulation by heterologous ligands is an important 
mechanism in the physiological response to a given factor. 
Other conditions of pancreatic growth are also associ- 
ated with an increase of the number of SS receptors. Thus, 
the hyperplasia of pancreatic tissue observed after proxi- 
mal small bowel resection is accompanied by an increase 
in the number of SS receptors at 2 weeks and 1 month 
after intestinal surgery [13]. In addition, the treatment of 
pancreatic tumor cells AR4-2J with gastrin and epidermal 
growth factor (EGF), which stimulate cell growth, in- 
creases the number of SS receptors [12]. However, the 
treatment with glucocorticoid, which decreases cell growth, 
decreases the number of SS receptors of AR4-2J cells [35]. 
The binding parameters of SS receptors in the control 
rats were similar to those previously reported by others 
[15-17,30]. Although at least five SS receptor subtypes 
have been cloned [36], the rat exocrine pancreas appears to 
express only the receptor subtype 2 (SSTR2) [37]. Re- 
cently, Dr. Susini's group has reported that the increase in 
SS receptor density induced by EGF and gastrin in pancre- 
atic tumor AR4-2J cells was due to up-regulation of 
SSTR2 subtype receptors [12]. Taken together, these re- 
suits suggest hat the increased SS receptor number in 
pancreatic acinar cell membranes during the lactation pe- 
riod (third week), which persisted for at least two weeks 
after weaning, could at least partly be the result of SSTR2 
subtype up-regulation. 
The observation of other authors [19,20,38] showing 
that SS activates guanylate cyclase are confirmed in the 
present study. Vesely [20] showed that SS enhanced 
guanylate cyclase activity in rat pancreas and in other 
organs such as stomach, liver, small intestine, brain and 
anterior pituitary gland. In the present study, SS stimulated 
basal guanylate cyclase activity in all the experimental 
groups. The ability of SS to stimulate guanylate cyclase is 
increased in rat pancreatic acinar membranes at the third 
week of lactation and at the second week after weaning 
compared with their controls. However, there did not 
appear to be any change in the number of molecules of 
guanylate cyclase since in basal conditions membranes 
from all the groups studied showed similar levels of 
activity. These results suggest that the increased activation 
of guanylate cyclase by SS in pancreatic acinar membranes 
at late lactation and the second week after weaning may be 
caused by increases in the number of SS receptors. 
When compared to controls, an increase in guanylate 
cyclase activity was observed at all the concentrations of
SS used, although it was only statistically significant at 1 
nM SS. The lack of significance at the other SS concentra- 
tions may be due to the dispersion of the results which 
would justify the S.E.M.s due to the use of crude mem- 
brane fractions. Although this significant effect of SS on 
guanylate cyclase activity was observed only at 1 nM SS, 
which is not compatible with the low circulating levels of 
the peptide, it is possible that the existence of an insulino- 
acinar axis may provide local concentrations of SS high 
enough to lead to this effect. 
To date, the role of cGMP in acinar cell function has 
been unclear. Several studies suggest hat in pancreatic 
acinar cells, cyclic GMP is a necessary and sufficient 
mediator of the agonist-stimulated Ca 2+ entry across the 
plasma membrane [39]. Recently, it has been suggested 
that the rise of intracellular calcium concentration could 
suppress cell growth in rat pancreatic AR42J cells [40]. 
Therefore, it is tempting to speculate that the increase of 
the effect of SS on guanylate cyclase activity during 
lactation could be related to the negative ffect on pancre- 
atic proliferation. Several studies support a role of cGMP 
in the inhibition of mesangial [21], smooth muscle [41] and 
endothelial cells [42]. In this context, it has recently been 
shown that SS increases cGMP in mesangial cells at the 
same time that it inhibits its proliferation [19]. 
The protein tyrosine kinase family of receptors [43] and 
possibly another forthcoming family of cell surface recep- 
tors containing protein tyrosine phosphatase activity [44,45] 
contain a single transmembrane domain like guanylate 
cyclase. Recently, our group has described a correlation 
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between guanylate cyclase activation and tyrosine phos- 
phatase activation in response to SS [46]. 
Recent light microscopic studies in the rat using India 
ink-injected tissues or scanning electron microscopic stud- 
ies of corrosion casts have confirmed that the capillaries of 
the islets of Langerhans emit efferent vessels to the capil- 
lary network in the exocrine tissue [24]. This microcircula- 
tory pattern has been referred to as the insulo-acinar portal 
system. Thus, because of the relatively short calculated 
plasma disappearance half-life of SS, which has been 
estimated to be approximately 1-2 min for SS-14 and 
approximately 4 min for SS-28 [47], it was suggested that 
islet-released SS might act via the insulo-acinar portal 
system [48]. Hence, despite low peripheral plasma levels, 
the relatively high local plasma concentrations which may 
be present around the acinar tissue would probably be 
functionally relevant [48]. Therefore, the present study 
measured the pancreatic SS content and found that pancre- 
atic SSLI levels had decreased after the third week of 
lactation and at the first two weeks after weaning. These 
results are in agreement with other experimental models of 
pancreatic growth studied by our group. Thus, two weeks 
after enterectomy, the situation is similar: increase of SS 
receptors and decrease of SSLI (although not significant 
after enterectomy). 
Previous studies have shown that gastrointestinal hor- 
mones such as gastrin, CCK, vasoactive intestinal peptide 
(VIP), SS, secretin, insulin and glucagon are released in 
response to suckling [5,49-51]. In addition, there is evi- 
dences that suckling activates the sympathetic nerves [5]. It 
has recently been demonstrated that CCK and sympathetic 
nerve activation increase SS secretion [5,52]. Therefore, 
the decrease in pancreatic SSLI levels in response to 
suckling could be a consequence of increased CCK plasma 
levels and sympathetic nerve activity. Recently, Bailey et 
al. [53] have described a decrease of SSLI content in the 
jejunum and colon of mice during lactation. This decrease 
of pancreatic SSLI levels agrees with the rise of SS plasma 
levels described in response to suckling [5]. In the present 
study, we found that the decrease in pancreatic SSLI 
content in the weaning group was less marked than in the 
late lactation group. In this regard, the abrupt ermination 
of the suckling stimulus after total weaning might result in 
a decrease in sympathetic stimulation [5], resulting in turn 
in an increase in pancreatic SSLI content with respect o 
late lactation, although it remained lower than controls. 
The hyperplasia of pancreatic tissue that occurs at late 
lactation and early weaning [3] together with the increase 
of activity by the SS receptor-effector system in pancreatic 
acinar membranes described in the present study support 
the view that SS may negatively regulate pancreatic acinar 
cell proliferation in vivo. This seemingly paradoxical se- 
quence of events which increase the activity of a growth 
inhibitor at a time of pancreatic acinar cell proliferation 
may, in fact, be an important mechanism that prevents 
uncontrolled growth during pancreatic proliferation. 
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